Pharma Journalist -

Acerus Pharmaceuticals Corporation announced that Hyundai Pharm Co., Ltd. (Hyundai), Acerus’ licensee, reported that South Korea’s Ministry of Food and Drug Safety (MFDS) has approved…
Read More...

STA Pharmaceutical, a subsidiary of WuXi AppTec, congratulates its partner Ascletis for receiving approval from National Drug Administration of China (CNDA, former CFDA) of its Category…
Read More...

SMi Group Reports: With less than 4 weeks left until the 13th annual ADMET Conference commences in London, SMi announces two new speakers joining the event. There is less than 4…
Read More...

Prana Biotechnology received ethics committee approval and has commenced recruitment for its Phase I Clinical trial evaluating the safety, tolerability and pharmacokinetics of the…
Read More...

Catalent Pharma Solutions announced that it has appointed Mr. Paul Hegwood as President of the company’s Clinical Supply Services business. He succeeds Mr. Wetteny Joseph, who was named…
Read More...

Alcami Corporation announced the expanded deployment of its Extended Workbench laboratory services program to support the ongoing manufacturing and development of ZILRETTA…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the United Kingdom’s National Institute for Health and Care Excellence (NICE) has published positive…
Read More...

SMi Group are delighted to welcome expertise from a senior panel of big pharma and cold chain organisations and regulatory bodies, at the 13th annual industry leading conference on Cold…
Read More...

Cambrex Corporation announced that it will expand research and development capabilities at its site in Paullo, Milan, Italy. The investment will be in the construction of a new 150m²…
Read More...

AbCellera Biologics announced the successful completion of the first phase of its collaboration with Denali Therapeutics. Under the collaboration, AbCellera applied its single-cell…
Read More...